查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917724

电子处方笺市场－2026年至2031年预测

E-Prescribing Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

电子处方笺市场预计将从 2025 年的 23.81 亿美元成长到 2031 年的 84.49 亿美元，复合年增长率为 23.5%。

电子处方笺市场是全球医疗保健领域数位转型的重要组成部分。电子处方笺是指医疗服务提供者向药房电子生成和传输处方笺的过程，这标誌着与传统纸质处方方式的根本性转变。该技术无需手写处方笺，简化了药物管理流程，并可直接与药房系统整合。提案其普及的核心价值在于：透过减少因字迹不清或剂量错误导致的用药错误来提高病患安全；提高临床运作效率；并促进病患更好地坚持用药并有效管理药物。随着全球医疗保健系统将数位化列为优先事项，对整合式电子配药解决方案的需求正在经历显着且持续的成长。

市场扩张的关键驱动因素是电子健康记录 (EHR) 的加速普及和更广泛的医疗保健数位化倡议。电子配药功能正日益成为综合 EHR 平台的核心模组，这为医疗机构采用这些整合系统提供了自然的途径。许多地区的政府政策和奖励计划正在积极推广使用经认证的 EHR 技术，包括电子配药功能，以提高医疗保健品质和互通性。这种监管和製度驱动因素，加上医疗保健产业对互联互通和数据驱动医疗的策略关注，正为门诊和住院环境中电子处方笺的普及提供强劲动力。

此外，电子配药解决方案的经济和营运效益正在推动其普及。这些系统透过消除列印、管理和实体传输纸处方笺等人工操作，切实降低了成本并提高了营运效率。它们减轻了临床人员的行政负担，最大限度地缩短了药房与患者的接触时间，并加快了处方笺配药流程。对于利润空间紧张的医疗机构而言，减少错误、提高员工效率和增强病患回应速度所带来的投资回报，为实施这些系统提供了强而有力的经济理由。反过来，这些效率的提高又促进了由药房支持的、更顺畅且不易出错的药品供应链的形成。

同时，技术进步也在推动市场发展。云端平台的演进使得先进的电子配药解决方案更易于取得和扩展，这对缺乏大规模IT基础设施的小规模诊所尤其有利。与行动应用程式的整合提高了医疗服务提供者的便利性，并透过诸如向智慧型手机发送电子处方笺等功能增强了病人参与。现代电子配药系统提供即时疗效验证、药物交互作用警报和处方笺核对工具等高级功能，超越了简单的电子传输，发展成为能够提高配药准确性和成本效益的主动决策支援系统。

从地理上看，北美已成为电子配药解决方案的领先市场。这一主导地位源于多种因素的共同作用，包括成熟的医疗资讯IT基础设施、电子健康记录（EHR）的早期广泛应用，以及透过立法和标准积极推动数位化处方笺的法规环境。医疗服务提供者和患者对电子配药益处的高度认知、主要供应商的存在以及完善的健康资讯网络，共同促成了电子配药解决方案在标准临床实践中的广泛应用。北美市场的特点是配药师和药房之间高度互联互通，这得益于确保互通性和安全资料交换的全国性网路。

竞争格局由几个关键参与企业组成。领先的电子病历 (EHR) 平台供应商，例如 Epic Systems Corporation 和 Cerner Corporation，利用其在医疗系统 IT 领域的强大地位，提供深度整合的电子配药模组，作为综合临床套件的一部分。同时，还有一些专注于先进药物历史管理服务、处方药监测计划 (PDMP) 整合以及安全的医药中心通讯平台的最佳组合专业电子配药解决方案提供商，例如 DrFirst Inc.。该生态系统的关键底层技术是医疗资讯网络，以 Surescripts 为代表，它经营一个连接配药机构、药房和支付方的全国性基础设施，从而实现大规模的安全资料交换。

该领域的主要企业持续致力于提升互通性、扩展临床决策支援功能，并与更广泛的医疗保健资料来源进行整合。其策略方向包括从基础处方笺工具转型为智慧药物管理平台。此发展趋势涵盖更全面的患者用药史、简化事前核准流程，以及在诊疗现场提供可操作的洞察。因此，市场发展轨迹将取决于其从单纯的效率工具向现代数位医疗框架内互联、安全、高效药物管理的关键组成部分的演变。

本报告的主要优势

  • 深入分析：获取主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业及其他细分市场。
  • 竞争格局：了解全球主要参与企业的策略倡议，并了解透过正确的策略进入市场的潜力。
  • 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
  • 可操作的建议：利用这些见解，在快速变化的环境中製定策略决策，发展新的商业机会和收入来源。
  • 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

报告范围：

  • 2021-2025年实际数据，2026-2031年预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区分類的收入和预测评估，包括国家/地区
  • 公司概况（策略、产品、财务资讯、重大发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

第五章 电子处方笺市场（依产品划分）

  • 介绍
  • 解决方案
  • 服务

6. 按交付方式分類的电子处方笺市场

  • 介绍
  • 基于网路的
  • 本地部署
  • 基于云端的

第七章 电子处方笺市场（依最终使用者划分）

  • 介绍
  • 医院
  • 诊所
  • 药局

第八章：各地区的电子处方笺市场

  • 介绍
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十章：公司简介

  • Cerner Corporation
  • Veradigm LLC（前身为 AllScripts）
  • athenahealth
  • NextGen Healthcare, Inc.
  • McKesson Corporation
  • Practice Fusion, Inc（acquired by Veradigm LLC）
  • Surescripts LLC
  • DrFirst
  • Medical Information Technology, Inc.（MEDITECH）

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615677

The E-Prescribing market , with a 23.5% CAGR, is projected to increase from USD 2.381 billion in 2025 to USD 8.449 billion in 2031.

The e-prescribing market is a critical component of the ongoing digital transformation within the global healthcare sector. E-prescribing, the process of electronically generating and transmitting prescription orders from healthcare providers to pharmacies, represents a fundamental shift from traditional paper-based methods. This technology eliminates handwritten scripts, streamlines the medication management workflow, and directly interfaces with pharmacy systems. The core value proposition driving adoption centers on enhancing patient safety by reducing medication errors related to illegibility or incorrect dosing, improving operational efficiency within clinical practices, and facilitating better medication adherence and management. As healthcare systems worldwide prioritize digitization, the demand for integrated e-prescribing solutions is experiencing significant and sustained growth.

A primary catalyst for market expansion is the accelerating adoption of Electronic Health Records (EHRs) and broader healthcare digitalization initiatives. E-prescribing functionality is increasingly embedded as a core module within comprehensive EHR platforms, creating a natural pathway for adoption as providers implement these integrated systems. Government policies and incentive programs in many regions actively promote the use of certified EHR technology, which includes e-prescribing capabilities, to improve care quality and interoperability. This regulatory and institutional push, combined with the healthcare industry's strategic focus on connectivity and data-driven care, creates a powerful driver for e-prescribing implementation across ambulatory and inpatient settings.

Furthermore, the compelling economic and operational benefits of e-prescribing solutions fuel their adoption. These systems deliver tangible cost savings and workflow efficiencies by eliminating manual processes associated with paper prescriptions, such as printing, handling, and physical transmittal. They reduce administrative burdens on clinical staff, minimize time spent on pharmacy callbacks for clarification, and accelerate the prescription fulfillment process. For healthcare organizations operating under margin pressures, the return on investment from reduced errors, improved staff productivity, and enhanced patient throughput provides a strong financial rationale for deployment. The efficiency gains extend to pharmacies, fostering a more seamless and error-resistant medication supply chain.

Concurrent technological advancements are also propelling the market forward. The evolution of cloud-based platforms has made sophisticated e-prescribing solutions more accessible and scalable, particularly for smaller practices without extensive IT infrastructure. Integration with mobile applications enhances accessibility for providers and can improve patient engagement through features like electronic prescription delivery to smartphones. Modern e-prescribing systems offer advanced functionalities such as real-time benefit checks, drug interaction alerts, and formulary compliance tools, moving beyond simple electronic transmission to become active decision-support systems that improve prescribing accuracy and cost-effectiveness.

Geographically, North America is established as the leading market for e-prescribing solutions. This leadership position is attributed to a confluence of factors: a mature healthcare IT infrastructure, early and widespread EHR adoption, and a regulatory environment that has actively encouraged digital prescribing through legislation and standards. High awareness of the benefits among both providers and patients, coupled with the presence of major technology vendors and well-established health information networks, has cemented widespread integration into standard clinical practice. The region's market is characterized by a high degree of connectivity between prescribers and pharmacies, facilitated by national networks that ensure interoperability and secure data exchange.

The competitive landscape is comprised of several key player segments. Major EHR platform vendors, such as Epic Systems Corporation and Cerner Corporation, offer deeply integrated e-prescribing modules as part of their comprehensive clinical suites, leveraging their entrenched position in health system IT. Alongside these are best-of-breed and specialized e-prescribing solution providers, like DrFirst Inc., which focus on advanced medication history services, prescription drug monitoring program (PDMP) integration, and secure provider-pharmacy communication platforms. A critical enabler in the ecosystem is the health information network, exemplified by Surescripts, which operates the national infrastructure connecting prescribers, pharmacies, and payers to facilitate secure data exchange at scale.

Leading companies in the space continue to focus on enhancing interoperability, expanding clinical decision support, and integrating with a wider array of healthcare data sources. The strategic direction involves moving from a foundational prescription routing tool to an intelligent medication management platform. This evolution includes incorporating more comprehensive patient medication histories, streamlining prior authorization processes, and providing actionable analytics at the point of care. The market's trajectory is thus defined by its progression from a discrete efficiency tool to an indispensable component of connected, safe, and efficient medication management within modern digital healthcare frameworks.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

E-Prescribing Market Segmentation

  • By Product
  • Solutions
  • Services
  • By Delivery Mode
  • Web-based
  • On-premise
  • Cloud-based
  • By End-User
  • Hospitals
  • Physician Offices
  • Pharmacies
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. E-PRESCRIBING MARKET BY PRODUCT

  • 5.1. Introduction
  • 5.2. Solutions
  • 5.3. Services

6. E-PRESCRIBING MARKET BY DELIVERY MODE

  • 6.1. Introduction
  • 6.2. Web-based
  • 6.3. On-premise
  • 6.4. Cloud-based

7. E-PRESCRIBING MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Physician Offices
  • 7.4. Pharmacies

8. E-PRESCRIBING MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Cerner Corporation
  • 10.2. Veradigm LLC (Formerly AllScripts)
  • 10.3. athenahealth
  • 10.4. NextGen Healthcare, Inc.
  • 10.5. McKesson Corporation
  • 10.6. Practice Fusion, Inc (acquired by Veradigm LLC)
  • 10.7. Surescripts LLC
  • 10.8. DrFirst
  • 10.9. Medical Information Technology, Inc. (MEDITECH)

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations